Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06893484

Assessment of Early Pregnancy MAB Completion

Assessing Completion of Medication Abortion for Very Early Pregnancies

Status
Recruiting
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
University of Washington · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

This is a prospective study to evaluate if successful completion of a medication abortion in patients with very early pregnancy can be detected with a urine pregnancy test at 2 weeks instead of 4 weeks. Additionally, the resolution of pregnancy symptoms in these patients will be characterized. Enrolled participants will take take weekly pregnancy tests and complete weekly questionnaires on their pregnancy symptoms for 4 weeks after their medication abortion.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTWeekly high-sensitivity urine pregnancy testsParticipants will take a high-sensitivity urine pregnancy test at home weekly for up to 4 weeks compared to the taking just one home urine pregnancy test at 4-5 weeks. Participants will also complete short weekly questionnaires on their pregnancy symptoms and follow-up care.

Timeline

Start date
2025-03-13
Primary completion
2026-03-01
Completion
2026-04-01
First posted
2025-03-25
Last updated
2025-06-05

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06893484. Inclusion in this directory is not an endorsement.

Assessment of Early Pregnancy MAB Completion (NCT06893484) · Clinical Trials Directory